Mycophenolate mofetil attenuates renal ischemia/reperfusion injury

Journal of the American Society of Nephrology

Volumn 13, Issue 10, 2002, Pages 2524-2533

  Ventura, Carlucci Gualberto ^a   Coimbra, Terezila Machado ^a   De Campos, Silvia Bernardete ^a   De Castro, Isac ^a   Yu, Luis ^a   Seguro, Antonio Carlos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0036785108     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000030143.73830.3C     Document Type: Article

References (41)

1. Shoes DA, Halloran PF: Delayed graft function in renal transplantation: Etiology, management and long-term significance. J Urol 155: 1837-1840, 1996
2. Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and nonspecific, early and late chronic events after organ transplantation: Transplant Rev 3: 93-103, 1996
3. Goes N, Urmson J, Ramassar V, Halloran PF: Ischemic acute tubular necrosis induces an extensive local cytokine response. Transplantation 59: 565-572, 1995
4. Shoskes DA, Parfrey NA, Halloran PF: Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 49: 201-207, 1990
5. Humes HD: Acute renal failure: Prevailing challenges and prospects for the future. Kidney Int 50: S26-S32, 1995
6. Mattos AM, Olyaei AJ, Bennet WM: Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challange for the future. Am J Kidney Dis 35: 333-346, 2000
7. Mele TS, Halloran PF: The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47: 215-145, 2000
8. Jayne D: Non-transplant uses of mycophenolate mofetil. Cur Opin Nephrol Hypert 8: 563-567, 1999
9. Allison AC, Eugui EM: Purine metabolism and immunosupressive effects of mycophenolate mofetil. Clin Transplant 348: 1357-1368, 1996
10. Allison AC, Eugui EM: Mycophenolate Mofetil and its mechanisms of action. Immunopharmacology 47: 85-118, 2000
11. Valentin JF, Bruijn JA, Paul L: Donor treatment with mycophenolate mofetil: Protection against ischemia-reperfusion injury in the rat. Transplantation 69: 344-350, 2000
12. Lan HY, Um W, Nikolic-Paterson DJ, Atkens RC: A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem 43: 97-102, 1995
13. Shih W, Hines WH, Neilson EG: Effects of cyclosporin A on the development of immune-mediated interstitial nephritis. Kidney Int 33: 1113-1118, 1988
14. nd ed., New York, Academic Press, 1974
15. Sollinger HW: Mycophenolate mofetil. Kidney Int 48: S14-S17, 1995
16. Andhon TF, Bennett WM: Nephrotoxicity of immunossupressive drugs: Experimental and clinical observations. Semin Nephrol 17: 34-45, 1997
17. Andhon TF, Burdmann EA, Lindsley J, Houghton DC, Bennett WM: Functional and structural characteristics of experimental FK 506 nephrotoxicity. Clin Exp Pharmacol Physiol 22: 646-654, 1995
18. Lieberthal W, Fuhro R, Abernethy VE, Koh JS, Rennke HG, Levine JS: Rapamycin delays recovery from acute ischemic renal failure in rats [Abstract]. J Am Soc Nephrol 10: 635A, 1999
19. Laurent AF, Dummont S, Poindron P, Muller CD: Mycophenolate mofetil supress protein N-linked glicosylation in human monocytes and their adhesion to endothelial cells and to some substrates. Exp Hematol 24: 59-67, 1996
20. Blaheta RA, Leckel K, Witting B: Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells. Transplant Proc 31: 1250-1252, 1999
21. Wang W, Tong MKH, Chan L: Mycophenolate mofetil protects against renal ischemia-reperfusion injury by inhibiting osteopontin and ICAM-1 expression [Abstract]. Transplantation 67: 537, 1999
22. Rabb HO, Meara YM, Maderna P, Coleman P, Brady HR: Leukocytes, cell adhesion molecule and ischemic renal failure. Kidney Int 51: 1463-1468, 1997
23. Molitoris BA, Marrs J: The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 106: 583-592, 1999
24. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int 43: 1160-1178, 1993
25. Kelly KJ, Willians WW, Colvin RB, Bonventre JV: Antibody to intercellular molecule-1 protects the kidney against ischemic injury. Proc Natl Acad Sci 91: 812-822, 1994
26. Haller H, Dragun D, Miethke A, Park JK, Weis A, Lippoldt A, Grob V, Luft FC: Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 50: 473-480, 1996
27. Kelly KJ, Willians WW, Colvin RB, Meehan SM, Springer TA, Ramos JCG, Bonventre JV: Intercellular Adhesion Molecule-1-deficient Mice are protected against ischemic renal injury. J Clin Invest 97: 1056-1063, 1996
28. Klausner JM, Paterson IS, Goldman G, Kobzic L, Rodzen C, Lawrence R, Valeri CR, Shepro D, Hechtman HB: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 256: F794-F802, 1989
29. Chiao H, Kohda Y, McLeroy P, Craig L, Lina S, Star RA: α-Melanocyte stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 54: 765-774, 1998
30. Lauriat S, Linas SL: The role of neutrophils in Acute Renal Failure. Semin Nephrol 18: 498-504, 1998
31. De Greef KE, Ysebaert DK, Ghielli M, Vercauteren S, Nouwen EJ, Eyskens EJ, De Broe ME: Neutrophils and acute ischemia-reperfusion injury. J Nephrol 11: 110-122, 1998
32. Ibrahim S, Jacob F, Zukin Y, Enriquez D, Holt D, Baldwin W, Sanfilippo F, Ratner LE: Immunohistochemical manifestations of unilateral kidney ischemia. Clin Transplant 10: 646-652, 1996
33. Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, De Broe ME: Identification and Kinetics of leukocytes after severe ischemia/reperfusion renal injury. Nephrol Dial Transplant 15: 1562-1574, 2000
34. Forbes JM, Hewitson TD, Becker GJ, Jones CL: Ischemic acute renal failure: Long-term histology of cell and matrix changes in rat. Kidney Int 57: 2375-2385
35. Rabb H, Daniels F, O Donnell M, Haq M, Saba SR, Keane W, Tang WW: Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 279: F525-F531, 2000
36. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL: The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 100: 1199-1203, 1997
37. Megyesi J, Di Mari J, Udvarhelyi N, Price PM, Sarfistein R: DNA syntesis is dissociated from the immediate-early gene response in the post-ischemic kidney. Kidney Int 48: 1451-1458, 1995
38. Nakopoulou L, Stefanaki K, Salpigidis K, Papadakis J, Zeiss PM, Vosnides G: The value of proliferating cell nuclear antigen (PCNA) cyclin in the assessment of cell proliferation in glomerulonephritis. Histol Histopathol 12: 655-662, 1997
39. Witzgall R, Brown D, Schawarz C, Bonventre JV: Localization of proliferating nuclear antigen, vimentin, c-Fos, and clusterin in postischemic kidney. J Clin Invest 93: 2175-2188, 1994
40. Nadady T, Laszic Z, Blick KE, Johnson DL, Burst-Singer K, Nast C, Cohen AH, Ormos J, Silva FG: Human acute tubular necrosis: A lectin and imunohistochemical study. Human Pathology 26: 230-239, 1995
41. Forbes JM, Hewitson TD, Becker GJ, Jones CL: Ischemic acute renal failure: Long term histology of cell and matrix changes in the rat. Kidney Int 57: 2375-2385, 2000